AJP - Endo Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 281: E665-E669, 2001;
0193-1849/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirano, T.
Right arrow Articles by Adachi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirano, T.
Right arrow Articles by Adachi, M.
Vol. 281, Issue 4, E665-E669, October 2001

Apoprotein C-III deficiency markedly stimulates triglyceride secretion in vivo: comparison with apoprotein E

Tsutomu Hirano, Toshihiro Takahashi, Shigenobu Saito, Hiroto Tajima, Tetsu Ebara, and Mitsuru Adachi

First Department of Internal Medicine, Showa University School of Medicine, Tokyo 142-8666, Japan

Apoprotein (apo) C-III plays an important role in the development of hypertriglyceridemia by inhibiting triglyceride (TG) removal. However, the effect of apo C-III on TG production remains unclear. We measured TG secretion rate (TGSR) in apo C-III gene-disrupted (apo C-III-null) mice to investigate the influence of this protein on TG turnover. TGSR measured by the Triton WR-1339 method was increased twofold in these mice compared with wild-type (WT) mice. Obesity was induced by the injection of gold-thioglucose (GTG), which made the WT mice hypertriglyceridemic due to a threefold increase of TGSR. However, GTG-induced obesity failed to increase TG in apo C-III-null mice, although TGSR was increased 10-fold, suggesting substantial stimulation of TG removal. Apo E-null mice were severely hypercholesterolemic but were not hypertriglyceridemic, and TGSR was rather decreased. GTG-induced obesity made these mice hypertriglyceridemic because of TG overproduction to an extent similar to that seen in WT mice. These results suggest that apo C-III deficiency potently enhances TG turnover, especially when TG production is stimulated, and that apo E deficiency is not always rate limiting for TG production.

apoprotein C-III; apoprotein E; triglyceride secretion; mice


This article has been cited by other articles:


Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
Z. Chen, M. C. Gropler, J. Norris, J. C. Lawrence Jr, T. E. Harris, and B. N. Finck
Alterations in Hepatic Metabolism in fld Mice Reveal a Role for Lipin 1 in Regulating VLDL-Triacylglyceride Secretion
Arterioscler Thromb Vasc Biol, October 1, 2008; 28(10): 1738 - 1744.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
J. S. Millar, D. A. Cromley, M. G. McCoy, D. J. Rader, and J. T. Billheimer
Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339
J. Lipid Res., September 1, 2005; 46(9): 2023 - 2028.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
G. Gerritsen, P. C. N. Rensen, K. E. Kypreos, V. I. Zannis, L. M. Havekes, and K. Willems van Dijk
ApoC-III deficiency prevents hyperlipidemia induced by apoE overexpression
J. Lipid Res., July 1, 2005; 46(7): 1466 - 1473.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
L.G Lyngdorf, S Gregersen, A Daugherty, and E Falk
Paradoxical reduction of atherosclerosis in apoE-deficient mice with obesity-related type 2 diabetes
Cardiovasc Res, October 1, 2003; 59(4): 854 - 862.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online